Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal study
- PMID: 33184080
- PMCID: PMC7662451
- DOI: 10.1136/bmjopen-2020-038953
Prevalence and predictors of poor sexual well-being over 5 years following treatment for colorectal cancer: results from the ColoREctal Wellbeing (CREW) prospective longitudinal study
Abstract
Objectives: To describe prevalence and predictors of poor sexual well-being for men and women over 5 years following treatment for colorectal cancer.
Design: Prospective longitudinal study, from presurgery to 5 years postsurgery, with eight assessment points. Logistic regression models predicted sexual well-being from presurgery to 24 months and 24 months to 60 months; time-adjusted then fully adjusted models were constructed at each stage.
Setting: Twenty-nine hospitals in the UK.
Participants: Patients with Dukes' stage A-C, treated with curative intent, aged ≥18 years and able to complete questionnaires were eligible.
Outcome measures: The dependent variable was the Quality of Life in Adult Cancer Survivors sexual function score. Independent variables included sociodemographic, clinical and psychosocial characteristics.
Results: Seven hundred and ninety participants provided a sexual well-being score for at least one time point. Thirty-seven per cent of men and 14% of women reported poor sexual well-being at 5 years. Baseline predictors for men at 24 months included having a stoma (OR 1.5, 95% CI 1.02 to 2.20) and high levels of depression (OR 2.69/2.01, 95% CI 1.68 to 4.32/1.12 to 3.61); men with high self-efficacy (OR confident 0.33/0.48, 95% CI 0.18 to 0.61/0.24 to 1.00; very confident 0.25/0.42, 95% CI 0.13 to 0.49/0.19 to 0.94) and social support (OR 0.52/0.56, 95% CI 0.33 to 0.81/0.35 to 0.91) were less likely to report poor sexual well-being. Predictors at 60 months included having a stoma (OR 2.30/2.67, 95% CI 1.22 to 4.34/1.11 to 6.40) and high levels of depression (OR 5.61/2.58, 95% CI 2.58 to 12.21/0.81 to 8.25); men with high self-efficacy (very confident 0.14, 95% CI 0.047 to 0.44), full social support (OR 0.26; 95% CI 0.13 to 0.53) and higher quality of life (OR 0.97, 95% CI 0.95 to 0.98) were less likely to report poor sexual well-being. It was not possible to construct models for women due to low numbers reporting poor sexual well-being.
Conclusions: Several psychosocial variables were identified as predictors of poor sexual well-being among men. Interventions targeting low self-efficacy may be helpful. More research is needed to understand women's sexual well-being.
Keywords: adult oncology; gastrointestinal tumours; health services administration & management; oncology; quality in health care.
© Author(s) (or their employer(s)) 2020. Re-use permitted under CC BY-NC. No commercial re-use. See rights and permissions. Published by BMJ.
Conflict of interest statement
Competing interests: Deborah Fenlon has received an honorarium from Roche.
Figures
Similar articles
-
Prevalence and determinants of depression up to 5 years after colorectal cancer surgery: results from the ColoREctal Wellbeing (CREW) study.Colorectal Dis. 2021 Dec;23(12):3234-3250. doi: 10.1111/codi.15949. Epub 2021 Nov 25. Colorectal Dis. 2021. PMID: 34679253 Free PMC article.
-
Does quality of life return to pre-treatment levels five years after curative intent surgery for colorectal cancer? Evidence from the ColoREctal Wellbeing (CREW) study.PLoS One. 2020 Apr 9;15(4):e0231332. doi: 10.1371/journal.pone.0231332. eCollection 2020. PLoS One. 2020. PMID: 32271835 Free PMC article.
-
Comorbidities are associated with poorer quality of life and functioning and worse symptoms in the 5 years following colorectal cancer surgery: Results from the ColoREctal Well-being (CREW) cohort study.Psychooncology. 2018 Oct;27(10):2427-2435. doi: 10.1002/pon.4845. Epub 2018 Sep 13. Psychooncology. 2018. PMID: 30070052 Free PMC article.
-
Psychosocial interventions for preventing and treating depression in dialysis patients.Cochrane Database Syst Rev. 2019 Dec 2;12(12):CD004542. doi: 10.1002/14651858.CD004542.pub3. Cochrane Database Syst Rev. 2019. PMID: 31789430 Free PMC article.
-
Biopsychosocial predictors of sexual function and quality of sexual life: a study among patients with colorectal cancer.Transl Androl Urol. 2015 Apr;4(2):206-17. doi: 10.3978/j.issn.2223-4683.2015.03.01. Transl Androl Urol. 2015. PMID: 26816825 Free PMC article. Review.
Cited by
-
Factors Associated With Quality of Life Among Colorectal Cancer Patients: Cross-Sectional Study.Cancer Control. 2024 Jan-Dec;31:10732748241302915. doi: 10.1177/10732748241302915. Cancer Control. 2024. PMID: 39557561 Free PMC article.
-
Sexual function remains persistently low in women after treatment for colorectal cancer and anal squamous cell carcinoma.J Sex Med. 2023 Mar 31;20(4):439-446. doi: 10.1093/jsxmed/qdac047. J Sex Med. 2023. PMID: 36805959 Free PMC article.
-
Sexual distress among men with cancer - a cross-sectional study.Acta Oncol. 2025 Feb 9;64:214-221. doi: 10.2340/1651-226X.2025.42525. Acta Oncol. 2025. PMID: 39924958 Free PMC article.
-
Erectile Dysfunction in Pelvic Cancer Survivors and Current Management Options.J Clin Med. 2023 Apr 4;12(7):2697. doi: 10.3390/jcm12072697. J Clin Med. 2023. PMID: 37048780 Free PMC article. Review.
-
A Prospective Study Evaluating Health-Related Quality of Life Following a Multimodal Treatment for Colorectal Cancer.J Gastrointest Cancer. 2023 Mar;54(1):117-125. doi: 10.1007/s12029-022-00802-6. Epub 2022 Jan 24. J Gastrointest Cancer. 2023. PMID: 35075581
References
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources
Medical